These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 24131305

  • 1. Influence of preformed donor-specific antibodies and C4d on early liver allograft function.
    Perera MT, Silva MA, Murphy N, Briggs D, Mirza DF, Neil DA.
    Scand J Gastroenterol; 2013 Dec; 48(12):1444-51. PubMed ID: 24131305
    [Abstract] [Full Text] [Related]

  • 2. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C, Willicombe M, Brookes PA, Santos-Nunez E, Bajaj R, Cook T, Roufosse C, Taube D, Warrens AN.
    Transplantation; 2013 Jan 27; 95(2):341-6. PubMed ID: 23197178
    [Abstract] [Full Text] [Related]

  • 3. Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy.
    Frank R, Molina MR, Goldberg LR, Wald JW, Kamoun M, Lal P.
    Am J Clin Pathol; 2014 Dec 27; 142(6):809-15. PubMed ID: 25389335
    [Abstract] [Full Text] [Related]

  • 4. Donor-Specific Anti-HLA Antibodies and Endothelial C4d Deposition-Association With Chronic Liver Allograft Failure.
    Iacob S, Cicinnati VR, Lindemann M, Heinemann FM, Radtke A, Kaiser GM, Kabar I, Schmidt HH, Baba HA, Beckebaum S.
    Transplantation; 2015 Sep 27; 99(9):1869-75. PubMed ID: 25706274
    [Abstract] [Full Text] [Related]

  • 5. Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts.
    Kozlowski T, Andreoni K, Schmitz J, Hayashi PH, Nickeleit V.
    Liver Transpl; 2012 Jun 27; 18(6):641-58. PubMed ID: 22298469
    [Abstract] [Full Text] [Related]

  • 6. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
    Ali S, Ormsby A, Shah V, Segovia MC, Kantz KL, Skorupski S, Eisenbrey AB, Mahan M, Huang MA.
    Transpl Immunol; 2012 Jan 27; 26(1):62-9. PubMed ID: 21907804
    [Abstract] [Full Text] [Related]

  • 7. The presence of anti-HLA donor-specific antibodies in lung allograft recipients does not correlate with C4d immunofluorescence in transbronchial biopsy specimens.
    Roberts JA, Barrios R, Cagle PT, Ge Y, Takei H, Haque AK, Burns KM, Land GA, Dilioglou S, Bernard DW.
    Arch Pathol Lab Med; 2014 Aug 27; 138(8):1053-8. PubMed ID: 24164556
    [Abstract] [Full Text] [Related]

  • 8. Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts.
    OʼLeary JG, Demetris AJ, Philippe A, Freeman R, Cai J, Heidecke H, Smith C, Hart B, Jennings LW, Catar R, Everly M, Klintmalm GB, Dragun D.
    Transplantation; 2017 Oct 27; 101(10):2399-2409. PubMed ID: 28665894
    [Abstract] [Full Text] [Related]

  • 9. Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients.
    Wahrmann M, Bartel G, Exner M, Regele H, Körmöczi GF, Fischer GF, Böhmig GA.
    Transpl Int; 2009 Oct 27; 22(10):982-9. PubMed ID: 19619171
    [Abstract] [Full Text] [Related]

  • 10. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A, Aguilera I, Gentil MA, Caro JL, Bernal G, Fernández Alonso J, Acevedo MJ, Cabello V, Wichmann I, Gonzalez-Escribano MF, Núñez-Roldán A.
    Transplantation; 2009 Jan 15; 87(1):94-9. PubMed ID: 19136897
    [Abstract] [Full Text] [Related]

  • 11. Correlation of circulating donor-specific anti-HLA antibodies and presence of C4d in endomyocardial biopsy with heart allograft outcomes: a single-center, retrospective study.
    Frank R, Molina MR, Wald JW, Goldberg LR, Kamoun M, Lal P.
    J Heart Lung Transplant; 2013 Apr 15; 32(4):410-7. PubMed ID: 23498162
    [Abstract] [Full Text] [Related]

  • 12. Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients.
    Bartel G, Wahrmann M, Schwaiger E, Kikić Ž, Winzer C, Hörl WH, Mühlbacher F, Hoke M, Zlabinger GJ, Regele H, Böhmig GA.
    Transpl Int; 2013 Feb 15; 26(2):121-30. PubMed ID: 23145861
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation.
    Cardarelli F, Pascual M, Tolkoff-Rubin N, Delmonico FL, Wong W, Schoenfeld DA, Zhang H, Cosimi AB, Saidman SL.
    Transpl Int; 2005 May 15; 18(5):532-40. PubMed ID: 15819801
    [Abstract] [Full Text] [Related]

  • 14. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
    Crespo M, Torio A, Mas V, Redondo D, Pérez-Sáez MJ, Mir M, Faura A, Guerra R, Montes-Ares O, Checa MD, Pascual J.
    Transpl Immunol; 2013 Dec 15; 29(1-4):28-33. PubMed ID: 23907088
    [Abstract] [Full Text] [Related]

  • 15. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
    Gosset C, Viglietti D, Rabant M, Vérine J, Aubert O, Glotz D, Legendre C, Taupin JL, Duong Van-Huyen JP, Loupy A, Lefaucheur C.
    Kidney Int; 2017 Sep 15; 92(3):729-742. PubMed ID: 28554738
    [Abstract] [Full Text] [Related]

  • 16. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
    Banasik M, Boratyńska M, Nowakowska B, Haloń A, Kościelska-Kasprzak K, Drulis-Fajdasz D, Patrzałek D, Weyde W, Klinger M.
    Transplant Proc; 2007 Nov 15; 39(9):2718-20. PubMed ID: 18021967
    [Abstract] [Full Text] [Related]

  • 17. Detection of plasma cells, C4d deposits and donor-specific antibodies on sequential graft biopsies of renal transplant recipients with chronic dysfunction.
    Martin L, Charon-Barra C, Bocrie O, Guignier F, D'Athis P, Dautin G, de la Vega MF, Justrabo E, Rifle G, Mousson C.
    Transpl Immunol; 2010 Feb 15; 22(3-4):110-4. PubMed ID: 19900552
    [Abstract] [Full Text] [Related]

  • 18. Significance and implications of capillaritis during acute rejection of kidney allografts.
    Cosio FG, Lager DJ, Lorenz EC, Amer H, Gloor JM, Stegall MD.
    Transplantation; 2010 May 15; 89(9):1088-94. PubMed ID: 20216485
    [Abstract] [Full Text] [Related]

  • 19. Prospective Monitoring of Donor-specific Anti-HLA Antibodies After Intestine/Multivisceral Transplantation: Significance of De Novo Antibodies.
    Kubal C, Mangus R, Saxena R, Lobashevsky A, Higgins N, Fridell J, Tector AJ.
    Transplantation; 2015 Aug 15; 99(8):e49-56. PubMed ID: 25769071
    [Abstract] [Full Text] [Related]

  • 20. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure.
    Gaston RS, Cecka JM, Kasiske BL, Fieberg AM, Leduc R, Cosio FC, Gourishankar S, Grande J, Halloran P, Hunsicker L, Mannon R, Rush D, Matas AJ.
    Transplantation; 2010 Jul 15; 90(1):68-74. PubMed ID: 20463643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.